Skip navigation
Speakers

Collaboration, Regulation and Innovation to Reduce the Risk of Addiction, Abuse, Misuse and Overdose

March 13-14, 2018
  • Silver Spring, MD

Chris Altomare
Director of Pharmaceutical Services
Drug Scan Inc.

Frederick R. Ball
Partner
Duane Morris

Jan Berger
CEO, Health Intelligence Partners;
Former Chief Clinical Strategist, Quantum Health;
Former Senior Vice President and Chief Clinical Officer,
CVS Caremark

Colville Brown, MD
Medical Director
Egalet

Amie Gehris
Technical Service Manager
Dow Food, Pharma & Medical, Company

Gary W. Jay, MD, FAAPM, FACFEI
Clinical Professor,
Department of Neurology, Division: Headache and Pain
University of North Carolina, Chapel Hill, NC

Bob Jones
CEO
Acura Pharmaceuticals

Sandra Morris
Principal, About Quality Benefits Design;
Former Senior Manager, Employee Benefit Design,
Procter and Gamble

Lauren B. Nelson, Esq.
Director, Policy and Regulatory Affairs
Massachusetts Department of Public Health,
Bureau of Health Professions Licensure

Steven Passik, PhD
Vice President, Scientific Affairs, Education and Policy
Collegium Pharmaceutical, Inc.

Piyush Patel
Formulation Technologies Manager
Colorcon

Brandon C. Presley
Abuse-Deterrent Formulations Team Leader
NMS Labs

Ronald E. Smith, MD, PhD
Board Certified Physician in Addiction Medicine,
Internal Medicine and Emergency Medicine;
Former Chairman, Department of Psychiatry,
National Naval Medical Center;
Psychiatric Consultant, Senate and House

Greg Sturmer
Chairman, CDO and Founder
Elysium Therapeutics

Douglas Throckmorton
Deputy Director, Regulatory Programs
FDA

Chris Altomare
Director of Pharmaceutical Services
Drug Scan Inc.

Frederick R. Ball
Partner
Duane Morris

Jan Berger
CEO, Health Intelligence Partners;
Former Chief Clinical Strategist, Quantum Health;
Former Senior Vice President and Chief Clinical Officer,
CVS Caremark

Colville Brown, MD
Medical Director
Egalet

Amie Gehris
Technical Service Manager
Dow Food, Pharma & Medical, Company

Gary W. Jay, MD, FAAPM, FACFEI
Clinical Professor,
Department of Neurology, Division: Headache and Pain
University of North Carolina, Chapel Hill, NC

Bob Jones
CEO
Acura Pharmaceuticals

Sandra Morris
Principal, About Quality Benefits Design;
Former Senior Manager, Employee Benefit Design,
Procter and Gamble

Lauren B. Nelson, Esq.
Director, Policy and Regulatory Affairs
Massachusetts Department of Public Health,
Bureau of Health Professions Licensure

Steven Passik, PhD
Vice President, Scientific Affairs, Education and Policy
Collegium Pharmaceutical, Inc.

Piyush Patel
Formulation Technologies Manager
Colorcon

Brandon C. Presley
Abuse-Deterrent Formulations Team Leader
NMS Labs

Ronald E. Smith, MD, PhD
Board Certified Physician in Addiction Medicine,
Internal Medicine and Emergency Medicine;
Former Chairman, Department of Psychiatry,
National Naval Medical Center;
Psychiatric Consultant, Senate and House

Greg Sturmer
Chairman, CDO and Founder
Elysium Therapeutics

Douglas Throckmorton
Deputy Director, Regulatory Programs
FDA